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The purpose of this study was to investigate expectancies regarding the interaction between cigarette smoking
and use of alcohol among alcohol-dependent smokers in early recovery, using the Nicotine and Other
Substances Interaction Expectancies Questionnaire (NOSIE). Participants were 162 veterans, 97% male, with
a mean age of 50 years, enrolled in a clinical trial aimed at determining the efficacy of an intensive smoking
cessation intervention versus usual care. At baseline, participants were assessed on measures of smoking
behavior, abstinence thoughts about alcohol and tobacco use, symptoms of depression, and smoking-substance
use interaction expectancies. In addition, biologically verified abstinence from tobacco and alcohol was
assessed at 26 weeks. Participants reported that they expected smoking to have less of an impact on substance
use than substance use has on smoking (p  .001). Severity of depressive symptoms was significantly
associated with the expectancy that smoking provides a way of coping with the urge to use other substances
(p  .01). The expectation that smoking increases substance urges/use was predictive of prospectively
measured and biologically verified abstinence from smoking at 26 weeks (p  .03). The results add to our
knowledge of smoking-substance use interaction expectancies among alcohol-dependent smokers in early
recovery and will inform the development of more effective counseling interventions for concurrent alcohol
and tobacco use disorders.
Keywords: smoking cessation, tobacco use, nicotine dependence, alcohol dependence, expectancies
More than one half of individuals receiving treatment for alco-
hol use disorders (AUDs) die from tobacco-related diseases (Hurt
et al., 1996). The prevalence and intensity of tobacco use are much
higher among individuals with current AUDs compared with the
general population (Lasser et al., 2000; Sobell, Sobell, & Agrawal,
2002). Although the overall prevalence of cigarette smoking has
declined in the United States, it has changed little among individ-
uals with AUDs (Fertig, 2002; Natinoal Institute of Alcohol Abuse
and Alcoholism [NIAAA], 1998; Sobell et al., 2002).
There is increasing interest in encouraging and assisting smok-
ers with AUDs to quit smoking while they are receiving substance
abuse treatment (Baca & Yahne, 2009). Efforts to develop more
effective cessation interventions for smokers in substance abuse
treatment settings can be facilitated by a more comprehensive
understanding of the bidirectional effects of tobacco and alcohol
use as well as the impact of the cessation of one of these sub-
stances on the use of the other. For example, studies of the
relationship between history of AUD, current alcohol use, and
smoking cessation indicate that history of AUD may be less
predictive of successful cessation failure than current heavy alco-
hol use (Hughes & Kalman, 2006; Leeman et al., 2008).
From a social–cognitive perspective, the study of expectancies
regarding interactions between smoking and substance use may help
identify perceived barriers to quitting smoking among individuals
with AUDs and strategies for overcoming these barriers (Rohsenow,
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Colby, Martin, & Monti, 2005). In a survey of alcohol-dependent
smokers (Asher et al., 2003), concerns about the effects of quitting
smoking on sobriety and the perceived need for cigarettes to cope
with negative mood associated with depression were endorsed by
almost half of the participants. Further investigations of expectancies
regarding the interaction of smoking and drug use are needed to
improve our understanding of barriers to quitting smoking in individ-
uals with AUDs. Given the high prevalence of depressive symptoms
and mood disorders in alcohol-dependent smokers and their associa-
tion with drug use behavior (Hall, Degenhardt, & Teesson, 2009;
Kodl et al., 2008; Patten, 2002), it makes sense to examine the
influence of depressive symptoms in the investigation of expectancies
in these complex patients.
To measure expectancies regarding the interaction between use
of tobacco and other substances, Rohsenow et al. (2005) developed
the Nicotine and Other Substances Interaction Expectancies Ques-
tionnaire (NOSIE). The NOSIE assesses expectancies regarding
the effects of smoking on substance use/urges, the effects of
substance use on smoking, smoking to cope with urges to use other
substances, and receptivity to smoking cessation during substance
abuse treatment. In the NOSIE development study (Rohsenow et
al., 2005), 160 patients enrolled in an inner-city residential sub-
stance abuse treatment program reported that substance use almost
always increased their smoking or urges to smoke, but that smok-
ing increased their substance use or urges much less frequently.
Despite the promising utility of the NOSIE, subsequent studies of
expectancies regarding the interaction of smoking and substance
use have been lacking.
In the present study, smoking-substance use interaction expectan-
cies were investigated in alcohol-dependent smokers in early recovery
who were enrolled in a clinical trial aimed at examining the efficacy
of an intensive intervention for smoking cessation. The primary ob-
jective of the present study was to replicate the findings of Rohsenow
et al. (2005) regarding relationships between smoking-substance use
interaction expectancies and use/cessation of tobacco, alcohol, and
other drugs and to build upon this work by investigating the influence
of symptoms of depression on these expectancies. Specifically, we
sought to investigate relationships between smoking-substance use
interaction expectancies and 1) various indices of concurrently mea-
sured smoking behavior; 2) abstinence thoughts about smoking and
alcohol use; 3) symptoms of depression; and 4) prospectively mea-
sured abstinence from tobacco, alcohol, and other substances. We
hypothesized that severity of depressive symptoms would be associ-
ated with a greater reliance on smoking to cope with the urge to drink.
Symptoms of depression and presence of depressive disorders have
been shown to influence addictive behavior, cessation attempts, and
vulnerability to relapse (Baker, Piper, McCarthy, Majeskie, & Fiore,
2004; Hall et al., 2009; Kodl et al., 2008; Patten, 2002). We also
hypothesized that receptivity to quitting smoking during substance
abuse treatment would be associated with desire to quit smoking and
prospectively measured abstinence from smoking, replicating one of
the findings of the Rohsenow et al. (2005) study.
Methods
Participants
Participants for the present study were 162 veterans (157
males and 5 females) recruited from the Drug and Alcohol
Treatment (DAT) programs at the San Francisco VA Medical
Center (SFVAMC) and VA Martinez Outpatient Clinic.
Eligibility criteria. DAT patients were considered eligible to
participate if they were 18 years old, reported alcohol as their
primary drug of abuse, were currently smoking  five cigarettes
daily, were abstinent from alcohol for at least seven days and not
more than 6 months, and reported an interest in quitting smoking.
Exclusion criteria included: any contraindications for nicotine
patches or adjuvant nicotine medications (e.g., unstable angina or
recent myocardial infarction, skin allergy to the nicotine patch,
severe cardiovascular disease, lactation, pregnancy by self-report
or by positive serum pregnancy test in premenopausal women),
unstable psychiatric disorder, and severe cognitive impairment.
Parent study smoking cessation interventions. Participants
were randomly assigned to intensive intervention or usual care.
The intensive smoking cessation intervention included 16 sessions
of cognitive behavior therapy (CBT) for smoking cessation, in-
cluding mood management, 4 months of nicotine patches, and 6
months of nicotine lozenges or gum. The mood management
component was implemented during Sessions 6 through 16 and
included cognitive restructuring and behavioral activation. Usual
care involved referral to the medical center’s smoking cessation
clinic. The smoking cessation intervention period lasted 6 months.
Of the 162 participants enrolled in the parent study, 117 (72%)
were available for the follow-up assessment at 26 weeks.
Measures
Smoking and substance use interaction expectancies. The
NOSIE Questionnaire (Rohsenow et al., 2005) consists of 20 items
and four reliable and valid expectancy scales measuring: 1) the
effects of substance use on smoking; 2) the effects of smoking on
substance use; 3) smoking to cope with the urge to use substances;
and 4) receptivity to smoking cessation during substance abuse
treatment. Results of the principal components analysis (PCA) and
Cronbach’s alpha supported the validity and internal consistency
reliability of the four NOSIE scales in the Rohsenow et al. (2005)
study. In the present study, the NOSIE was administered at base-
line. Cronbach’s alphas for the four NOSIE subscales in the
present study ranged from .64 for subscale 4 (receptivity to smok-
ing cessation during substance abuse treatment) to .90 for subscale
1 (effects of substance use on smoking).
Use of tobacco, alcohol, and other drugs. To assess ciga-
rette smoking status at baseline and point-prevalence abstinence at
26 weeks, participants were asked: 1) “Have you smoked ciga-
rettes in the past seven days?” and 2) “On average, how many
cigarettes do you currently smoke per day?” The Alcohol/Drugs
subsection from the ASI (McLellan et al., 1992; McLellan et al.,
1985; McLellan, Luborsky, Woody, & O’Brien, 1980) was used to
characterize substance use patterns and other substance- and
treatment-related variables. Expired-air carbon monoxide (CO 
10 ppm) was used to validate self-reported point-prevalence ab-
stinence from smoking at 6 months. The ASI was also used to
assess 30-day alcohol use/abstinence at 26 weeks. Breathalyzer
was used to validate self-report of abstinence from alcohol use at
26 weeks.
Nicotine dependence. Nicotine dependence was measured on
the Fagerström Test for Nicotine Dependence at baseline (FTND;
Heatherton, Kozlowski, Frecker, & Fagerström, 1991). The FTND
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has good internal consistency and construct validity (Payne, Smith,
McCracken, McSherry, & Antony, 1994).
Abstinence thoughts. The Thoughts about Abstinence Form
(Hall, Havassy, & Wasserman, 1990; Hall, Havassy, & Wasser-
man, 1991; Wasserman, Stewart, & Delucchi, 2001) was used at
baseline to assess desire to quit using tobacco and alcohol and
expected success in quitting these substances.
Depressive symptoms. Level of depressive symptoms was
assessed on the Beck Depression Inventory at baseline (BDI; Beck,
Ward, Mendelsohn, Mock, & Erbaugh, 1961). The BDI was used
rather than the BDI-II because the BDI was used as a “core
battery” assessment across multiple studies by our group of inves-
tigators.
Analysis
Correlational analyses and multiple regressions were calculated
to examine bivariate and multivariate relationships between each
of the four smoking-substance use interaction expectancies and
baseline measures of tobacco and alcohol use, abstinence thoughts,
and depressive symptoms. In the correlational analyses, the depen-
dent variables, measured at baseline, included: number of ciga-
rettes per day, number of days of alcohol use, total score on the
BDI, desire to quit smoking, desire to quit drinking, expected
success in quitting smoking, and expected success in quitting
drinking. Four multiple regression models were estimated and
tested to examine predictors of the four NOSIE expectancies. In
these analyses, independent variables (measured at baseline) in-
cluded number of cigarettes per day, number of days of alcohol
use, total score on the BDI, desire to quit smoking, desire to quit
drinking, expected success in quitting smoking, and expected
success in quitting drinking. Two additional multiple regression
analyses were used to determine the association between smoking-
substance use interaction expectancies and prospectively measured
and biologically verified abstinence from tobacco and alcohol at
26 weeks. In both of these models, independent variables, mea-
sured at baseline, included duration of recovery at the time of
enrollment in the study, number of cigarettes per day, number of
days of alcohol use, total score on the BDI, desire to quit smoking/
drinking, expected success in quitting smoking/drinking, and all
four NOSIE expectancy variables.
Results
Study Sample Baseline Characteristics
The study sample consisted of all military Veterans, 97% male,
with 48% identifying as Caucasian and 37% identifying as African
American. Participants were on average 50 years old, unmarried
(91% single), with a high school education or less (69%). A total
of 81% of participants were unemployed, 83% had an annual
income less than $21,000, 43% reported that they lived in half way
houses/therapeutic communities, and 26% were homeless. As
shown in Table 1, the baseline mean score on the FTND was 4.1
(SD  2.37) and average smoking rate was 17 cigarettes per day
(SD  10.48). The baseline mean score on the ASI Psychiatric
Status Index was 0.25 (SD  0.25), exceeding the mean score of
0.10 for the general population (McLellan et al., 1992; McLellan
et al., 1985).
Smoking-Substance Use Interaction Expectancies
The mean scores on NOSIE-assessed expectancies for the pres-
ent study sample were compared with mean scores in the earlier
study (Rohsenow et al., 2005). Participants in the present study
reported significantly greater impact of substance use on cigarette
smoking than participants in the earlier study, t 4.04, ES 0.45,
df  160, p  .001; similar impact of smoking on substance
use/urges, t  1.27, ES  0.14, ns, less use of smoking to remain
abstinent from alcohol and other drugs, t  2.10, ES  0.24, df 
160, p .04; and more receptivity to quitting smoking during their
substance abuse treatment, t  5.68, ES  0.64, df  160, p 
.001. In addition, participants expected smoking to have less of
an impact on the urge to use substances than the impact of
substance use has on the urge to smoke, t  17.46, df  160,
ES  1.38, p  .001.
Association of NOSIE Expectancies With Use of
Tobacco and Alcohol, Abstinence Thoughts, and Mood
As shown in Table 2, receptivity to quit smoking during sub-
stance abuse treatment was positively associated with the desire to
quit both alcohol and smoking and expected success in quitting
both. Most of the significant correlations in Table 2 represented
small effects with the exception of the larger correlation between
desire to quit smoking and receptivity to quitting smoking during
substance abuse treatment.
The results of the multiple regression models indicated that
desire to quit smoking (PE  0.117) was associated with the
expectancy that smoking increases the urge to use other substances
(R2 0.08, F 2.70, p .02). The BDI total score was predictive
of the expectancy that smoking provides a way of coping with the
urge to use substances (R2 0.05, PE 0.021, t 2.61, p .01).
Desire to quit smoking (PE  0.17) and the FTND total score
(PE  0.057) were significant predictors of receptivity to quit
smoking during substance abuse treatment (R2  0.20, F  7.62,
p  .0001). Desire to quit smoking was positively associated with
receptivity to quit smoking during substance abuse treatment and
Table 1
Smoking, Mood, and NOSIE Variables
Variable Mean SD
Smoking
Cigarettes usually smoked in 24 hours 16.8 10.48
Years of smoking 31.8 10.52
Age first tried cigarettes 13.6 4.15
Age began smoking regularly 18.2 6.47
Times quit smoking at least one week 5.1 12.97
FTND total score 4.1 2.37
Psychological distress
ASI Psychiatric Status Index 0.25 0.25
BDI Total Score 14.1 10.55
POMS Total Mood Disturbance score 44.8 47.20
NOSIE Scales
Substances increase tobacco use/urges 4.28 0.99
Smoking increases substance use/urges 2.62 1.15
Smoking to cope with substance urges 2.23 1.02
Receptive to quitting during treatment 4.02 0.72
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the FTND total score was inversely related to this NOSIE expec-
tancy variable.
Association of NOSIE Expectancies With Prospectively
Measured Abstinence From Cigarettes and Alcohol
As shown in Table 3, the expectation that smoking increases
substance urges/use was significantly predictive of prospectively
measured and CO-verified abstinence from cigarettes at 26 weeks
(p  .03). None of the four NOSIE expectancies were found to be
associated with verified abstinence from alcohol at 26 weeks (all
ps  .05).
Discussion
Participants in the present study who expected smoking to have
an impact on the urge to use substances reported a greater desire to
quit smoking and demonstrated a higher verified quit rate from
smoking at 26 weeks. This expectancy may have served as a
source of motivation for quitting smoking and remaining abstinent.
That is, concern about the impact of smoking on substance use
may have motivated smokers to quit and stay quit as a way of
safeguarding their sobriety. The potential benefit of assessing and
addressing expectancies regarding the interaction of smoking and
substance use needs to be further explored in future studies of
tobacco use cessation interventions with alcohol-dependent smok-
ers in early recovery.
Participants who reported being more receptive to quitting
smoking during substance abuse treatment also reported being
more motivated to quit smoking and anticipated being more suc-
cessful in quitting smoking. Since these variables were assessed
concurrently and the relationships were cross-sectional, it is not
possible to make causal inferences. In addition, none of these
motivational and expectancy factors were found to be predictive of
prospectively measured verified abstinence from smoking. In con-
trast, Rohsenow et al. (2005) found that receptivity to quitting
smoking during substance abuse treatment was predictive of pro-
spectively measured quitting behavior at 1 month. Differences in
the characteristics of the two study samples must be taken into
account in the interpretation of this finding. Although the two
study samples were similar in terms of demographics, substance
abuse backgrounds, and current enrollment in treatment, partici-
pants in the present study were predominately male, all military
Veterans, and varied more in their duration of sobriety. Future
studies are warranted to investigate relationships between these
motivational and expectancy variables and prospectively measured
response to smoking cessation interventions aimed at increasing
receptivity to cessation, intentions to quit, and actual quit attempts,
and reducing attitudinal barriers to cessation.
It has been suggested that alcohol-dependent smokers in early
recovery may require more counseling designed to increase their
receptivity and self-efficacy for quitting smoking during alcohol/
drug treatment (Burling, Ramsey, Seidner, & Kondo, 1997). The
belief that quitting smoking may interfere with their recovery from
substance abuse may reduce enthusiasm for concurrent (i.e., within
first 6 months of recovery) smoking cessation. Providing informa-
tion that counters this mistaken belief may enhance motivation for
quitting. Additional assessment of the belief that quitting smoking
may interfere with recovery from substance use may find that
some alcohol-dependent smokers do not endorse this belief. On
average, the participants in the Rohsenow et al. (2005) study did
Table 2
Zero-Order Correlations Between the NOSIE Subscales and




1 2 3 4
Cigarettes per day .17 .22 .01 .07
Years of smoking .09 .02 .01 .01
Times quit smoking  24 hours .07 .12 .08 .04
FTND Total Score .18 .21 .03 .03
Days using alcohol in past 30 days .10 .10 .05 .25
BDI Total Score .06 .07 .21 .18
Desire to quit smoking .10 .16 .06 .40
Expected success quitting smoking .07 .02 .03 .30
Desire to quit alcohol .08 .04 .07 .23
Expected success quitting alcohol .03 .01 .07 .28
Note. NOSIE Subscales: 1 Substances increase tobacco use/urges, 2
Smoking increases substance use/urges, 3  Smoking to cope with sub-
stance urges, 4  Receptive to quitting smoking during substance abuse
treatment; FTND  Fagerström Test of Nicotine Dependence; BDI 
Beck Depression Inventory.
 p  .01.  p  .001.
Table 3
Multiple Regression Model: Predictors of Prospectively Measured and CO-Verified Abstinence
From Cigarettes at 26 Weeks
Covariates Parameter estimate SE Wald Chi-Square P value
Duration of recovery 0.022 0.110 0.042 0.837
Average cigarettes per day 0.02 0.040 0.374 0.541
FTND 0.278 0.187 2.212 0.137
BDI 0.001 0.033 0.002 0.961
Desire to quit smoking 0.066 0.217 0.093 0.760
Substances increase smoking urges/use 0.557 0.306 3.306 0.069
Smoking increases substance use/urges 0.779 0.358 4.729 0.030
Smoking to cope with substance urges 0.021 0.317 0.004 0.947
Receptive to quitting during treatment 0.131 0.493 0.071 0.790
Note. FTND  Fagerström Test of Nicotine Dependence; BDI  Beck Depression Inventory.
361EXPECTANCIES OF ALCOHOL-DEPENDENT SMOKERS
not endorse the belief that smoking cessation during substance
abuse treatment would interfere with recovery. Some, but not all
alcohol-dependent smokers in early recovery believe that quitting
smoking will interfere with their sobriety. The efficacy of coun-
seling and educational approaches that include the assessment and
discussion of expectancies regarding smoking-substance use inter-
actions needs to be further investigated with this population of
smokers.
The present study extended the work of Rohsenow et al. (2005)
by investigating the relationship between severity of depressive
symptoms and expectancies regarding smoking-substance use in-
teractions. Participants in the present study who reported more
severe depressive symptoms had stronger expectations regarding
the role of smoking to cope with the substance use/urges and were
less receptive to quitting smoking during their substance abuse
treatment. Kodl et al. (2008) examined the effects of depressive
symptoms on abstinence from tobacco and alcohol after treatment
for alcohol and nicotine dependence and found that depressive
symptoms were prospectively related to alcohol use, but were not
related to subsequent tobacco use. Different and more intensive
treatment strategies focusing on mood management may be needed
for alcohol-dependent smokers with higher levels of depressive
symptoms (Patten, 2002).
Several studies have investigated the role of smoking as a
strategy to cope with the urge to drink. Compared with the par-
ticipants in the Rohsenow et al. (2005) study, the present study
sample reported a significantly lower expectancy that smoking
provides a way of coping with substance use/urges. The partici-
pants in the Rohsenow et al. (2005) study reported using smoking
to cope with urges to use substances about half of the time.
According to the cross-substance coping response hypothesis
(Monti, Rohsenow, Colby, & Abrams, 1995), smoking is viewed
as a means of coping with cravings for alcohol. Similarly, drinking
may be used to cope with cravings for cigarettes. However, re-
search on cross-substance coping has yielded inconsistent results
(Carter & Tiffany, 1999). A majority of smokers in alcohol treat-
ment have not reported any benefit from using such a coping
strategy (Asher et al., 2003; Kalman et al., 2001; Monti et al.,
1995).
There were limitations in the present study that need to be
considered in interpreting the results. The NOSIE measures ex-
pectancies regarding the interaction between smoking and sub-
stance use and is not specific to expectancies regarding the inter-
action between smoking and alcohol use. Second, the present study
sample was predominantly male and entirely military Veterans.
Since the earlier study (Rohsenow et al., 2005) did not find gender
differences on any of the NOSIE variables, the fact that the current
sample was mostly male is less of a concern. Third, the associa-
tions between smoking-substance use interaction expectancies and
measures of depressive symptoms and abstinence thoughts were
cross-sectional, limiting inferences about causal relationships.
Fourth, the large number of analyses introduced the risk of Type I
error and most of the significant correlations represented small
effects.
There is growing evidence to support the encouragement of
smoking cessation among alcohol-dependent smokers in early
recovery, that is, concurrent cessation of cigarettes, alcohol, and
other drugs (Gulliver, Kamholz, & Helstrom, 2006; Kalman, 1998;
Prochaska, Delucchi, & Hall, 2004; Sobell et al., 2002). Still,
tobacco use cessation outcomes in this group of smokers have been
less than optimal due to a number of factors. For instance, alcohol-
dependent tobacco smokers are more likely to come from a back-
ground of socioeconomic disadvantage (Daeppen et al., 2000) and
lack effective coping skills for managing dysphoric mood states
and substance-related urges (Burling et al., 1997; Steinberg, Hall,
& Rustin, 2004). Therefore, tobacco and alcohol cessation out-
comes may be enhanced by interventions that minimize the impact
of depressive symptoms, cognitive deficits, low self-efficacy, and
lack of desire to quit (Gordon, Kennedy, & McPeake, 1988).
There are an increasing number of empirical studies aimed at
developing more effective smoking cessation treatments for smok-
ers with AUD and successfully integrating such interventions
within the substance abuse treatment and primary care settings
(Drake, Mercer-McFadden, Mueser, McHugo, & Bond, 1998;
Thompson et al., 1988). As research on treatment efficacy moves
more in the direction of considering interactions between specific
intervention components, process factors, and patient attributes
(Imel, Wampold, Miller, & Fleming, 2008), the investigation of
expectancies regarding interactions between smoking and drug use
will be useful in designing more effective interventions for ciga-
rette smokers with alcohol and other substance use disorders.
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